YIH
ATYR

Y-Intercept (HK)’s aTyr Pharma ATYR Stock Holding History

Y-Intercept (HK)’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.4K Buy
+22,373
New +$14.6K ﹤0.01% 1645
2025
Q2 		– Sell
-12,583
Closed -$38K – 2093
2025
Q1 		$38K Buy
+12,583
New +$45.9K ﹤0.01% 1138
2024
Q2 		– Sell
-43,892
Closed -$85.6K – 2007
2024
Q1 		$85.6K Buy
+43,892
New +$76.6K 0.01% 1291

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Y-Intercept (HK)'s ATYR Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in aTyr Pharma (ATYR) in Q2 2026: 22,373 shares worth $13.4K. The stake represents ﹤0.01% of the portfolio and ranks #1645 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in ATYR as recently as Q1 2025.

Y-Intercept (HK) first reported a position in ATYR in Q1 2024 and has held it in 3 quarters since. The position peaked at $85.6K in Q1 2024. 90 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

  • Y-Intercept (HK) held 22,373 shares of aTyr Pharma worth $13.4K as of Q2 2026.
  • aTyr Pharma was a new Y-Intercept (HK) position in Q2 2026.
  • aTyr Pharma made up ﹤0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1645 holding.
  • Y-Intercept (HK) first reported a position in aTyr Pharma in Q1 2024 and has held it in 3 quarters since.
  • Y-Intercept (HK)'s aTyr Pharma position peaked at $85.6K in Q1 2024.
  • 90 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.